Search clinical trials for: Mycophenolic acid drugs

Total 257711 results

Mahidol University

Enrolling by invitation

Oral Branched-chain Amino Acid Supplementation for Cirrhotic Patients With Sarcopenia (BCAASarcopenia)

Sarcopenia | Cirrhosis of the Liver

Thailand
University of Nebraska
Genzyme, a Sanofi Company

Completed

Improved Induction and Maintenance Immunosuppression in Kidney Transplantation

End-stage Renal Disease

United States
University of California, Los Angeles
Novartis

Completed

Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®

Signs and Symptoms, Digestive | Gastrointestinal Lesions

United States
Nanjing University School of Medicine

Completed

MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis

Vasculitis | Anti-Neutrophil Cytoplasmic Antibody

China
Penn State University
United States Department of Agriculture (USDA)

Completed

Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation

Inflammation | Cardiovascular Disease

United States
Mayo Clinic

Completed

Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids

Obesity | Barrett's Esophagus

United States
Novartis Pharmaceuticals

Completed

Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Simultaneous Pancreas-Kidney Transplants

Kidney Transplantation | Pancreas Transplantation

Germany
Panacea Biotec Ltd

Completed

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition

Healthy Volunteers

India
McMaster University
Ajinomoto USA, INC.

Completed

Impact of Varying Doses of Amino Acids on Exercise, Muscular and Mental Performance

Psychological Phenomena: Central Fatigue

Canada
Columbia University
Pfizer; Cornell University

Completed

Using mTOR Inhibitors in the Prevention of BK Nephropathy

BK Viremia | BK Nephropathy

United States
Mirum Pharmaceuticals, Inc.

Completed

Efficacy of To Be Marketed (TBM) Cholic Acid Capsules Used to Treat Children With Inborn Errors of Bile Acid Synthesis

Inborn Errors of Bile Acid Synthesis

United States
University College, London

Completed

Citrulline Challenge Study for Healthy Subjects in the United Kingdom (CHS-UK)

Intestinal Diseases

United Kingdom
Northumbria University

Completed

Exercise-induced Muscle Damage is Reduced in Resistance Trained Athletes by Branch Chain Amino Acids

Exercise-induced Muscle Damage
Panacea Biotec Ltd

Completed

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition

Healthy Volunteers

India
University of Illinois at Urbana-Champaign

Completed

Muscle Protein Synthesis in Dialysis Patients

Muscle Loss

United States
AstraZeneca

Completed

A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI (PRECISE)

Diabetes Mellitus, Type 2 | Exocrine Pancreatic Insufficiency

Sweden, Poland, Latvia, Denmark, Hungary, Slovakia
Teva Branded Pharmaceutical Products R&D, Inc.
Parexel

Terminated

Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients

Stable Renal Transplant Recipients
Novartis

Completed

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients

Kidney Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)

Renal Transplantation
Texas A&M University

Unknown

Chronic Obstructive Pulmonary Disorder and Acute Exercise

Pulmonary Disease, Chronic Obstructive

United States
Oklahoma Medical Research Foundation
NYU Langone Health

Completed

Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis

Arthritis | Systemic Lupus Erythematosus

United States
Novartis Pharmaceuticals

Completed

Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients

Kidney Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients

Kidney Transplant

Korea, Republic of
Astellas Pharma Global Development, Inc.
Basilea Pharmaceutica International Ltd

Completed

A Study to Assess the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Mycophenolate Mofetil in Healthy Adult Subjects

Healthy Subjects | Pharmacokinetics of Isavuconazole | Pharmacokinetics of Plasma Mycophenolic Acid (MPA) | Pharmacokinetics of Plasma Phenolic Glucuronide of MPA (MPAG)

United States
Novartis Pharmaceuticals

Terminated

MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive

De Novo Kidney Transplant
Novartis

Completed

Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants

Renal Transplantation
Novartis

Completed

Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids

Denovo Renal Transplantation
Thomas Jefferson University
GlaxoSmithKline; Drexel University

Unknown

A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)

Quality of Life | Inflammation | Sickle Cell Disease | HEMOGLOBIN SS | Hemoglobin S Beta-0 Thalassemia

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment

HIV Infections
Northwestern University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis

Systemic Sclerosis | Lung Diseases, Interstitial | Scleroderma

United States
Novartis

Completed

A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients.

Kidney Transplantation
Novartis Pharmaceuticals

Completed

An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients

Kidney Transplant Recipients
Prisma Health-Midlands

Terminated

Immunonutrition for Diabetic Foot Ulcers

Diabetes Mellitus | Diabetic Foot Ulcer | Diabetic Peripheral Neuropathy

United States
Genentech, Inc.

Withdrawn

A Study to Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal Transplantation

Kidney Transplantation
Fred Hutchinson Cancer Center
University of Washington

Completed

MMF for HIV Reservoir Reduction

Human Immunodeficiency Virus I Infection

United States
Biogen

Terminated

BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis (ATLAS)

Lupus Nephritis

United States, Peru, Belgium, Italy, Philippines, Malaysia, Hong Kong, Argentina, Germany, Hungary, Australia, Colombia, Russian Federation, Portugal, Mexico, Korea, Republic of, France, Thailand, Brazil, Poland, Spain
Biogen

Terminated

BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis

Lupus Nephritis

Belgium, Peru, Italy, Malaysia, Australia, Argentina, United States, Hong Kong, Hungary, Poland, Colombia, Russian Federation, Philippines, Brazil, France, Korea, Republic of, Mexico, Spain, Thailand
Children's Hospital Medical Center, Cincinnati
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Recruiting

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study (PLUMM)

Lupus Nephritis

United States
Hoffmann-La Roche

Completed

Study to Compare the Pharmacokinetics of Mycophenolate Mofetil Metabolites From Four Tablet Formulations in Healthy Participants

Healthy Volunteers

New Zealand
University of Oslo School of Pharmacy

Terminated

Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant

Renal Transplantation

Norway
Novartis Pharmaceuticals

Terminated

Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients

Kidney Transplantation

Italy
University of California, San Francisco
Aravind Eye Hospitals, India

Completed

First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial (FAST)

Uveitis

India
Elizabeth Anne Thiele
Ajinomoto Co., Inc.; Ajinomoto USA, INC.

Not yet recruiting

Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy

Drug Resistant Epilepsy | Refractory Epilepsy

United States
University of Nebraska
University of Colorado, Denver; University of Pittsburgh; Children's Hospital...

Completed

Smith-Lemli-Opitz Syndrome and Cholic Acid

Smith-Lemli-Opitz Syndrome

United States
Dayanand Medical College and Hospital

Active, not recruiting

Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C

Liver Cirrhosis

India
University of Alabama at Birmingham
University of Michigan

Completed

REduCing Immunogenicity to PegloticasE (RECIPE) Study (RECIPE)

Gout Chronic

United States
Samsung Medical Center

Unknown

Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept (NODAT)

Diabetes

Korea, Republic of
Ramesh Prasad
Hoffmann-La Roche

Terminated

Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients (MMCR)

Cardiovascular Diseases | Kidney Transplantation

Canada
Novartis Pharmaceuticals

Completed

Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients.

Kidney de Novo Transplant
Novartis Pharmaceuticals

Completed

Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients

Renal Transplantation

Germany

3

Subscribe